Dabigatran-

As of October 21, 2024, this test has been discontinued.  There is no alternative test available.

Test info

  
Dabigatran
  
DABLC
  
Direct Thrombin Inhibitor
Pradaxa®
  

Measurement of drug level in order to monitor therapeutic level and/or diagnose under-dosage or potential toxicity.

Specimen

  
Sodium citrate (Na cit) plasma
  

Lt blue Sodium citrate (NaCit) - 2.7mL

If the patient has a hematocrit >55, a specially prepared Lt blue Sodium citrate (NaCit) tube must be used in place of the standard Lt blue Sodium citrate (NaCit) tube.

Hematocrit-Anticoagulant adjustments

  
1.0 mL
  
0.5 mL (Note: This volume does not allow for repeat testing.)
  

Do not over or under fill the tube as the ratio of anticoagulant to whole blood is critical for accurate results

Coag – tube fill guideline

Immediatley following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  
  1. Process Platelet Poor Plasma (P.P.P).

  2. Transfer plasma into a Transfer vial/tube with cap - 12mL (LabCorp) and apply a spot label "NaCit Plasma P.P.P"

  
  
Plasma
  
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

 

  

1. Spin within 2 hours of sample collection

2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as plasma

  
  

Ambient (preferred) - 7 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x3

 

  
  • Hemolyzed specimens
  • Patient on heparin > 1.0 IU/mL
  • Specimen exceeds standard testing time
  • Unlabeled or mislabeled specimen
  • Clotted specimen
  • Over/under filled tube (incorrect volume)

Performance

  
LabCorp (117076); R-LC
  
4-7 days
  

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

Clinical and Interpretive info

Billing

  
80299

Tracking

  
10/31/2011
  
10/21/2024
  
08/15/2023